GRI Bio, Inc.
GRI· Nasdaq
Released Aug 14, 2025, before the open
10-Q filed Aug 14, 2025, 45 days after period end · 0001824293-25-000106
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$2.89M | -$2.25M | -$6.75M | -$295.00K |
| EPS Diluted | -$36.72 | -$61.85 | -$239.37 | -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end
+10.0% from the close of Aug 13, 2025 to the close of Aug 14, 2025, the first after the release.